Marco Salvetti


Titolo Pubblicato in Anno
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience NEUROTHERAPEUTICS 2024
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach MULTIPLE SCLEROSIS 2024
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report NEUROLOGICAL SCIENCES 2024
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) NEUROLOGICAL SCIENCES 2024
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Sars-CoV2 infection in pregnant women with multiple sclerosis MULTIPLE SCLEROSIS 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? EUROPEAN JOURNAL OF NEUROLOGY 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation MULTIPLE SCLEROSIS AND RELATED DISORDERS 2023
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients NEUROLOGICAL SCIENCES 2023
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review FRONTIERS IN IMMUNOLOGY 2023
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis FRONTIERS IN IMMUNOLOGY 2023
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors NEUROLOGICAL SCIENCES 2023
Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study NEUROLOGICAL SCIENCES 2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients FRONTIERS IN IMMUNOLOGY 2023
Response to “Frailty in multiple sclerosis: A closer look at the deficit accumulation framework” MULTIPLE SCLEROSIS 2022
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study MULTIPLE SCLEROSIS 2022
A clinical and epidemiological prevalence study on Friedreich’s Ataxia in Latium, Italy NEUROEPIDEMIOLOGY 2022
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome SCIENTIFIC REPORTS 2022
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy EBIOMEDICINE 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma